Successful treatment of methicillin-resistant Staphylococcus aureus Keratitis with topical ciprofloxacin.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 1800931.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Ciprofloxacin is a new quinolone antibiotic with a broad spectrum of activity against most aerobic gram-positive and gram-negative bacteria. Topical ciprofloxacin (3 mg/ml) was used to treat bacterial keratitis caused by methicillin-resistant strains of Staphylococcus aureus in two patients. Both corneal ulcers had been previously treated with other antibiotics without success. Topical ciprofloxacin was curative in both cases. The authors recommend the use of topical ciprofloxacin for methicillin-resistant S. aureus keratitis.
Medical subject headings
- Ciprofloxacin
- Corneal Ulcer
- Eye Infections, Bacterial
- Methicillin Resistance
- Staphylococcal Infections
- Staphylococcus aureus